Tags: US | Eli | Lilly | Alzheimers | drug

Eli Lilly Halts Development of Alzheimer's Drug

Tuesday, 17 Aug 2010 08:20 AM

Drugmaker Eli Lilly and Co. is stopping development of one of its potential Alzheimer's disease treatments in late-stage patient testing.

The Indianapolis company says early results from two studies of semagacestat show the treatment did not slow the disease's progression and was tied to some worsening clinical measures.

Lilly still has another potential Alzheimer's treatment in late-stage testing, and the drugmaker said this decision will not affect that drug.

Lilly will face the expiration of patents protecting several top-selling drugs in the next few years, and last week it learned a U.S. District Court judge ruled a patent protecting the attention deficit hyperactivity drug Strattera was invalid.

Shares of the drugmaker slipped 2.4 percent in premarket trading.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
Companies
Drugmaker Eli Lilly and Co. is stopping development of one of its potential Alzheimer's disease treatments in late-stage patient testing.The Indianapolis company says early results from two studies of semagacestat show the treatment did not slow the disease's progression...
US,Eli,Lilly,Alzheimers,drug
117
2010-20-17
Tuesday, 17 Aug 2010 08:20 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved